Global Anaemia Drugs Market Expected to Grow at a CAGR of 8% by 2032, Driven by Growing Prevalence of CKD Anaemia

The global market for anaemia drugs is being driven by the growing prevalence of CKD anaemia segment over the forecast period as chronic kidney diseases are becoming prevalent across many regions. Further, the exponential growth of e-commerce segment as a distribution channel, is expected to foster the market growth of anaemia drugs due to user convenience. The market is dependent on many factors like the rising geriatric population, rapid R&D activities, and better healthcare infrastructure that are predicted to fuel the overall growth of the market.

The market is further driven by the ongoing developments by the key industry players like Pfizer Inc. and Amgen Inc. (NASDAQ: AMGN). On 15 May 2018, Pfizer Inc. announced that the US Food and Drug Administration (FDA) has given approval to RETACRIT® (epoetin alfa-epbx), which is a biosimilar to Epogen® and Procrit® (epoetin alfa)1, for all indications of the mentioned product. RETACRIT® is claimed to offer patients and their physicians more access to high-quality, lower-cost alternative treatment option for anaemia and a decrease in allogeneic RBC transfusions in certain patients. Such developments in the field of anaemia drugs to address the advancing needs of patients and the vast healthcare community are predicted to aid the market growth over the forecast period.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Anaemia Type, Drugs, Distribution Channel, and Region:

• The anaemia drugs industry, on the basis of anaemia type, is divided into iron deficiency, CKD (chronic kidney disease), sickle cell, and aplastic, among others.

• Based on drugs, the industry is segmented into dietary supplements and medicines.

• On the basis of distribution channel, the industry is categorised into hospital pharmacy, store pharmacy, and online, among others.

• Regionally, the market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The global market for anaemia drugs is driven by the rising prevalence of this condition in children and women.

• The market is further aided by several factors like unhealthy lifestyle, high number of women of reproductive age, development of pipeline products, and complications during pregnancy, especially in developing countries.

• In addition, rise in geriatric population, enhancing health care infrastructure, and rapid R&D are expected to propel the market growth over the forecast period.

Key Offerings of the Report:

• The EMR report gives an overview of the global market for anaemia drugs for the periods (2018-2023) and (2024-2032).

• The report also offers the historical (2018-2023) and forecast (2024-2032) markets for the anaemia types, drugs, distribution channels, and major regions of anaemia drugs. 

• It gives an in-depth look at the regional price trends in the global market for anaemia drugs.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

Amgen Inc., Pieris Pharmaceuticals, Inc., Pfizer Inc., Akebia Therapeutics, Inc., Takeda Pharmaceutical Company Limited, among others are the key players in the global anaemia drugs market. The EMR report looks into the capacity, market share, and latest developments of these major players like plant turnarounds, mergers and acquisitions, and capacity expansions.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-579